FALCONE, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 275
EU - Europa 80
AS - Asia 65
AF - Africa 10
SA - Sud America 3
Totale 433
Nazione #
US - Stati Uniti d'America 254
CN - Cina 33
CA - Canada 21
IT - Italia 14
EG - Egitto 10
FR - Francia 10
NL - Olanda 10
KR - Corea 9
DE - Germania 8
GB - Regno Unito 8
IN - India 7
RU - Federazione Russa 7
JP - Giappone 6
MY - Malesia 3
SE - Svezia 3
TW - Taiwan 3
UA - Ucraina 3
AT - Austria 2
CO - Colombia 2
ES - Italia 2
FI - Finlandia 2
GR - Grecia 2
HU - Ungheria 2
VN - Vietnam 2
AR - Argentina 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
Totale 433
Città #
Des Moines 28
Fairfield 28
Houston 26
Ann Arbor 18
Woodbridge 17
Seattle 16
Wilmington 15
Ashburn 11
Beijing 9
Santa Cruz 8
Buffalo 7
Cambridge 6
Palermo 5
Wuhan 5
Boston 4
Columbus 4
Edmonton 4
Lanzhou 4
San Diego 4
Toronto 4
Chongqing 3
Cortona 3
Dallas 3
Hangzhou 3
Mountain View 3
Santa Clara 3
Seoul 3
Stockholm 3
Barranquilla 2
Bronx 2
Calgary 2
Hanoi 2
Helsinki 2
Las Vegas 2
Norwalk 2
Ottawa 2
Phoenix 2
Pune 2
Reston 2
Sibu 2
Taoyuan District 2
Tokyo 2
Amsterdam 1
Athens 1
Barcelona 1
Bengaluru 1
Boardman 1
Bogen 1
Boulder 1
Calvisano 1
Castle Rock 1
Davis 1
Denver 1
Doncaster 1
Dublin 1
Dumbarton 1
Dunfermline 1
Edinburgh 1
Engesvang 1
Federal 1
Frankfurt am Main 1
Geneva 1
Gurgaon 1
Hamilton 1
Hasselt 1
Heidelberg 1
Henderson 1
Hillside 1
Ibaraki 1
Innsbruck 1
Katy 1
Kavála 1
Kenmore 1
Lissone 1
Montreal 1
Montréal 1
Mordelles 1
Moscow 1
Mumbai 1
Nanjing 1
Neuilly-plaisance 1
North Arlington 1
Northport 1
Palma De Mallorca 1
Paris 1
Providence 1
Radstock 1
Rennes 1
San Mateo 1
Sanford 1
Saskatoon 1
Scranton 1
Serra 1
Shanghai 1
Shenyang 1
Taipei 1
Tehran 1
Tucson 1
University Park 1
Vancouver 1
Totale 333
Nome #
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC), file e3ad8917-51db-da0e-e053-3705fe0a2b96 440
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance?, file e3ad891e-f062-da0e-e053-3705fe0a2b96 4
Totale 444
Categoria #
all - tutte 703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 13 8
2019/202070 4 5 10 7 8 4 5 7 6 3 7 4
2020/202163 4 10 4 0 8 2 5 3 13 1 12 1
2021/202291 7 9 6 17 17 5 4 5 5 3 10 3
2022/202370 3 3 8 5 2 5 30 4 2 1 4 3
2023/202427 1 2 5 3 2 0 1 3 1 4 5 0
Totale 444